Compare HLIO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLIO | LMAT |
|---|---|---|
| Founded | 1970 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 1996 | 2006 |
| Metric | HLIO | LMAT |
|---|---|---|
| Price | $85.94 | $93.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $66.17 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 353.3K | 254.8K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | 0.72% | ★ 0.93% |
| EPS Growth | 23.93 | ★ 30.57 |
| EPS | 0.59 | ★ 0.68 |
| Revenue | $200,727,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $3.67 | $14.21 |
| Revenue Next Year | $5.00 | $8.88 |
| P/E Ratio | $144.19 | ★ $134.76 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $31.21 | $79.01 |
| 52 Week High | $85.85 | $118.01 |
| Indicator | HLIO | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 74.16 | 35.69 |
| Support Level | $63.09 | $82.26 |
| Resistance Level | N/A | $114.38 |
| Average True Range (ATR) | 2.57 | 2.99 |
| MACD | 0.45 | -0.41 |
| Stochastic Oscillator | 90.64 | 27.34 |
Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.